ICD-10-CM Billable Code

C83.55

Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb

Clinical Classification Guidelines

Medical Intelligence & Overview

Lymphoblastic lymphoma is a type of aggressive non-Hodgkin lymphoma that originates from immature lymphocytes, usually T-cells. When this cancer affects the lymph nodes of the inguinal region (groin) and the lower limbs, it can significantly impact those areas. This form of lymphoma tends to grow quickly and requires prompt diagnosis and treatment. Understanding its characteristics, causes, symptoms, and available treatment options can provide valuable insight into this complex disease.

Causes & Symptoms

Clinical Causes: Genetic mutations in lymphocyte cells that lead to uncontrolled growth Immunodeficiency conditions, which weaken the body's ability to fight abnormal cells Certain viral infections, such as Epstein-Barr virus (EBV), may increase risk History of prior cancer treatments like chemotherapy or radiation Environmental exposures to certain chemicals or toxins Family history of lymphomas or other hematologic cancers

Key Symptoms: Swelling or lumps in the groin or lower limbs Persistent pain or discomfort in affected areas Unexplained weight loss Night sweats Fever that doesn't go away Persistent fatigue or weakness Skin changes or redness over swollen lymph nodes Difficulty walking or swelling that impairs limb movement

Diagnostic & Treatment

Diagnosis Path: Physical examination focusing on enlarged lymph nodes and affected areas Imaging studies such as ultrasound, CT scans, or PET scans to evaluate the extent Biopsy of affected lymph nodes to identify the characteristic lymphoblasts Laboratory tests, including blood counts and blood chemistry Immunophenotyping and molecular studies to classify the lymphoma subtype Bone marrow biopsy may be performed if systemic involvement is suspected

Treatment Protocols: Chemotherapy regimens designed to target rapidly dividing lymphoma cells Immunotherapy, such as monoclonal antibodies, to enhance the immune response Radiation therapy in some cases to reduce or control local disease Stem cell transplants in cases resistant to initial treatments Supportive care to manage symptoms and prevent infections during therapy Regular follow-up to monitor for remission or recurrence

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C83.55 a billable ICD-10 code?
Yes, C83.55 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C83.55?
Clinical documentation must specify the nature of Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference